Lummis S C, Martin I L
MRC Molecular Neurobiology Unit, MRC Centre, Cambridge, UK.
Mol Pharmacol. 1992 Jan;41(1):18-23.
5-Hydroxytryptamine3 (5-HT3) receptors from N1E-115 neuroblastoma cells were solubilized using 1.1% n-octylglucoside; five other detergents were less effective. Purification was achieved by affinity chromatography using immobilized GR119566X and biospecific elution with quipazine. Saturation analyses with [3H] GR67330 binding revealed high affinity binding to homogeneous populations of sites in both the solubilized (Kd = 0.05 +/- 0.02 nM) and purified (Kd = 0.10 +/- 0.04 nM) preparations. Competition experiments indicated that the solubilized and purified receptor preparations retained the characteristics observed in N1E-115 cells in vivo. Polyacrylamide gel electrophoresis of the purified receptor revealed a single protein band of 54.7 +/- 1.3 kDa. The purified receptor was incorporated into liposomes, and the functional integrity of the protein was demonstrated by measurement of m-chlorophenylbiguanide-stimulated 22Na uptake. Saturation analysis of the reconstituted preparation revealed a Kd of 0.24 +/- 0.07 nM and suggested that 0.2% of 5-HT3 receptors present in the original membrane preparation had been incorporated into liposomes.
使用1.1%的正辛基葡糖苷溶解N1E-115神经母细胞瘤细胞中的5-羟色胺3(5-HT3)受体;其他五种去污剂的效果较差。通过使用固定化的GR119566X进行亲和色谱和用喹哌嗪进行生物特异性洗脱来实现纯化。用[3H]GR67330结合进行的饱和分析表明,在溶解的制剂(Kd = 0.05 +/- 0.02 nM)和纯化的制剂(Kd = 0.10 +/- 0.04 nM)中,均与均一的位点群体具有高亲和力结合。竞争实验表明,溶解的和纯化的受体制剂保留了在体内N1E-115细胞中观察到的特性。纯化受体的聚丙烯酰胺凝胶电泳显示出一条54.7 +/- 1.3 kDa的单一蛋白带。将纯化的受体掺入脂质体中,并通过测量间氯苯基双胍刺激的22Na摄取来证明该蛋白的功能完整性。重组制剂的饱和分析显示Kd为0.24 +/- 0.07 nM,并表明原始膜制剂中存在的5-HT3受体的0.2%已掺入脂质体中。